云南白药6.6亿元收购聚药堂，高负债率与低业绩承诺引关注

Core Viewpoint - Yunnan Baiyao Group announced the acquisition of 100% equity in An Guo Shi Ju Yao Tang Pharmaceutical Co., Ltd. for a total consideration of 660 million yuan, aiming to expand its presence in the traditional Chinese medicine sector [1][2] Group 1: Acquisition Details - The acquisition involves cash payment and is structured through a share transfer agreement with existing shareholders of Ju Yao Tang [1] - The share transfer prices for the shareholders are as follows: 2.31 million yuan for 35% equity, 1.32 million yuan for 20%, 1.12 million yuan for 17%, and 924,000 yuan each for 14% equity held by two other shareholders [1] Group 2: Ju Yao Tang's Business Profile - Ju Yao Tang specializes in the production and sales of traditional Chinese medicine pieces, including toxic and directly consumable varieties, with a comprehensive product line of 1,567 types [2] - The company has a robust B2B online sales model with 100,000 registered users and 53,000 cumulative trading customers, primarily targeting pharmacies and clinics [2] Group 3: Strategic Implications for Yunnan Baiyao - The acquisition is expected to enhance Yunnan Baiyao's market expansion outside its current regions and improve its product pipeline with Ju Yao Tang's extensive offerings [2] - Ju Yao Tang's established online sales channels and customer base are anticipated to provide significant strategic synergies, improving operational efficiency in Yunnan Baiyao's traditional medicine supply chain [2] Group 4: Financial Performance and Commitments - Ju Yao Tang's projected revenue for 2024 is approximately 632 million yuan, with a net profit of about 69.33 million yuan [4] - The company has committed to lower net profit targets for the next three years compared to 2024, raising market speculation about future performance [3][6] - The financial commitments for 2025 to 2027 include revenue targets of approximately 624 million yuan, 616 million yuan, and 666 million yuan, with net profit targets of 66 million yuan, 59.7 million yuan, and 63.9 million yuan respectively [6] Group 5: Financial Health and Risks - As of March 31, Ju Yao Tang had total assets of approximately 747 million yuan and total liabilities of about 426 million yuan, resulting in a debt ratio of approximately 57.02% [6] - The high debt ratio may pose a challenge for Yunnan Baiyao in optimizing Ju Yao Tang's financial structure post-acquisition [6][7]